Teva Pharmaceutical Industries Ltd
TEVA
查看详细走势图
29.625USD
+0.855+2.97%
交易中 （美东）报价延迟15分钟
34.06B总市值
24.06市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+2.97%
5天
-1.55%
1月
-12.66%
6月
+53.74%
今年开始到现在
-5.08%
1年
+83.10%
查看详细走势图
TradingKey Teva Pharmaceutical Industries Ltd股票评分
单位: USD 更新时间: 2026-03-24操作建议
Teva Pharmaceutical Industries Ltd当前公司基本面数据相对稳定，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在药品行业排名45/157位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价38.35。中期看，股价处于平稳状态。近一个月，市场表现较差，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Teva Pharmaceutical Industries Ltd评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
极度看空
Teva Pharmaceutical Industries Ltd亮点
亮点风险
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
业绩转盈
公司业绩转盈，最新年度盈利美元
估值高估
公司最新PE估值23.66，处于3年历史高位
机构减仓
最新机构持股665.23M股，环比减少17.10%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓，最新持仓市值12.75K
分析师目标
根据
13
位分析师
买入
评级
38.355
目标均价
+33.50%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Teva Pharmaceutical Industries Ltd新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Teva Pharmaceutical Industries Ltd简介
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
公司代码TEVA
公司Teva Pharmaceutical Industries Ltd
CEOFrancis (Richard D)
网址https://www.tevapharm.com/
相关品种
